Search

Two studies on multiple myeloma provide new information about diagnosing and treating this blood cancer.

… Monday, December 9, 2019 Summary One study looked at a new drug combination for this blood cancer; the other focused on genetic markers linked to how the disease progresses. Multiple myeloma is a cancer that arises from the type of white blood cells called plasma cells. When normal plasma cells in the

Sloan Kettering Institute investigators have found that a subpopulation of cells within a type of sarcoma called malignant peripheral nerve sheath tumor appear to be similar to a type of neural stem cells.

… Monday, June 14, 2021 Neurofibromatosis type 1 (NF1) is the most common hereditary disease of the nervous system. Overall, it is a rare condition that affects about one in 3,000 people in the United States and worldwide. It is characterized by tumors that grow along the peripheral nerves (the nerves

Patients with secondary rectal cancer after radiotherapy for prostate cancer have shorter survival compared with matched treatment-naïve patients. However, a new study by investigators at MSK has found distinct differences in patient characteristics, available treatment options, and tumor biologic characteristics that may explain the gap.

… Tuesday, April 29, 2025 Patients with secondary rectal cancer (SRC) after radiotherapy (RT) for prostate cancer have shorter survival compared with matched treatment-naïve patients,  (1) but factors explaining this gap have been unclear. Now, a new study by investigators at Memorial Sloan Kettering Cancer

Learn about Anna-Katerina “Kat” Hadjantonakis, who is Chair of the Sloan Kettering Institute’s Developmental Biology Program.

… Monday, December 30, 2019 Earlier this year, Anna-Katerina “Kat” Hadjantonakis was named Chair of the Sloan Kettering Institute ’s Developmental Biology Program. She succeeded Kathryn Anderson , who had led the program since it launched in 2003. We spoke with Dr. Hadjantonakis about the field of developmental

Samuel Singer has been appointed Chief of the Gastric and Mixed Tumor Service in the Department of Surgery.

… Monday, February 1, 2010 Summary Samuel Singer has been appointed Chief of the Gastric and Mixed Tumor Service in the Department of Surgery. Samuel Singer has been appointed Chief of the Gastric and Mixed Tumor Service in the Department of Surgery. Dr. Singer is a surgical oncologist and leader of Memorial

There are more than 100 subtypes of brain tumors, making them a challenge to accurately diagnose. Now researchers have figured out a way to reliably distinguish them.

… Wednesday, March 14, 2018 Summary Proper diagnosis and classification is vital for brain tumors , but until now it hasn’t been easy. This week an international team of investigators is reporting a new way to distinguish among the 100-plus different subtypes of the disease. There are more than 100 subtypes

VEXAS syndrome is a confounding adult-onset inflammatory disease first described in 2020, which affects 1 in 4,000 men over 50. Now, MSK researchers are shedding new light on its mechanisms and laying the groundwork for potential targeted treatments.

… Monday, November 3, 2025 Researchers at Memorial Sloan Kettering Cancer Center (MSK) have developed some of the first robust laboratory models of a confounding adult-onset inflammatory disease called VEXAS syndrome — shedding new light on its mechanisms and laying the groundwork for potential targeted

An MSK clinical trial found that participating in integrative therapy classes online could benefit cancer patients in active treatment, not only by reducing fatigue, anxiety, and depression but also lowering hospitalization rates.

… Tuesday, June 17, 2025 As Jan Gura prepared to face the onslaught of standard treatments for stage 2 ovarian cancer, she knew she also wanted integrative therapies that would help her feel better.  “I didn’t know how my body would respond to chemotherapy, but I’ve always been an active person. Being

En un ensayo clínico de MSK se descubrió que participar en clases de terapia integral en línea podría beneficiar a los pacientes que padecen cáncer y reciben tratamiento activo, no solo porque reduce la fatiga, la ansiedad y la depresión, sino también porque disminuye las tasas de hospitalización.

… Tuesday, June 17, 2025 Mientras Jan Gura se preparaba para enfrentarse a la avalancha de tratamientos estándar para el cáncer de ovario en estadio 2, sabía que también quería terapias integrales que la ayudaran a sentirse mejor.  “No sabía cómo respondería mi cuerpo a la quimioterapia, pero siempre he

A gift from the estate of renowned fashion designer Geoffrey Beene will enable MSKCC to launch an ambitious research initiative to be known as the Geoffrey Beene Cancer Research Center.

… Wednesday, September 27, 2006 A gift from the estate of renowned fashion designer Geoffrey Beene will enable Memorial Sloan Kettering Cancer Center (MSKCC) to launch an ambitious research initiative to be known as the Geoffrey Beene Cancer Research Center . It will build on MSKCC’s strong existing scientific